The role of MDCK-based influenza vaccine Influvac®TC in (inter)pandemics

International Congress Series

Volumn 1263, Issue C, 2004, Pages 822-825

  Medema, Jeroen K ^a   Wijnands, D Thomas ^a   Palache, Abraham M ^a  

^a Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Cell culture; Influenza; MDCK; Pandemic; Vaccine

Indexed keywords

EID: 84929332386     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2004.02.107     Document Type: Article

References (6)

1. Resolution of the 56th World Health Assembly, Prevention and control of influenza pandemics and annual epidemics, WHA 56.19, 28th May 2003.
2. WHO Memorandum, Bull. W.H.O. 73 (1995), 431–435.
3. Brands, R, et al. Inactivated influenza vaccines prepared on cell culture. Brown, T, Robertson, J.S., Schild, G.C., Wood, J.M., (eds.) Dev. Biol. Stand., 98, 1999, Karger, Basel, 93–100.
4. van Essen, G.A., et al. Vaccine 21 (2003), 1780–1785.
5. United Nations Population Division, http://esa.un.org/unpp/p2k0data.asp.
6. J.K. Medema, Y.F. Zoellner, J. Ryan, A.M. Palache, accepted for publication in Virus Research 2004.